Acarbose was effective in maintaining glycemic control in type 2 diabetes mellitus but was associated with adverse effects
Hoofdauteurs: | Holman, R, Dinneen, S |
---|---|
Formaat: | Journal article |
Taal: | English |
Gepubliceerd in: |
1999
|
Gelijkaardige items
-
The effect of combination therapy of sulfonylurea, metformin, and acarbose in type 2 diabetes mellitus patients
door: Tri Murti Andayani,, et al.
Gepubliceerd in: (2009-12-01) -
A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)
door: Holman, R, et al.
Gepubliceerd in: (1999) -
Effects of the addition of acarbose to insulin and non-insulin regimens in veterans with type 2 diabetes mellitus
door: Wettergreen SA, et al.
Gepubliceerd in: (2016-12-01) -
Improved glycemic control by acarbose therapy in hypertensive diabetic patients: effects on blood pressure and hormonal parameters
door: P. Rosenbaum, et al.
Gepubliceerd in: (2002-08-01) -
Impact of baseline characteristics on glycemic effects of add‐on saxagliptin or acarbose to metformin therapy: Subgroup analysis of the SMART study in Chinese patients with type 2 diabetes mellitus
door: Hui Fang, et al.
Gepubliceerd in: (2020-07-01)